Skip to content
Screener

Gossamer Bio, Inc. GOSS Q4 2025 Annual earnings

Reported March 17, 2026 · Before market open

Revenue$13.8MBeat by $6.3M
EPS-$0.21Miss by $0.01
Revenue estimate$7.5M
EPS estimate-$0.20

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$10.7M
EPS estimate-$3.81

FAQ

When did Gossamer Bio, Inc. report Q4 2025 earnings?
Gossamer Bio, Inc. (GOSS) reported Q4 2025 earnings on March 17, 2026 before market open.
What were Gossamer Bio, Inc.'s Q4 2025 revenue and EPS?
Gossamer Bio, Inc. reported revenue of $13.8M and eps of $-0.21 for Q4 2025.
Did Gossamer Bio, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $7.5M by $6.3M. EPS missed the consensus estimate of $-0.20 by $0.01.
How did Gossamer Bio, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 47.1% from $9.4M a year earlier and eps declined 40.0% from $-0.15.
Where can I find Gossamer Bio, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001728117-26-000018) and the 10-K periodic report (0001728117-26-000017) directly on SEC EDGAR. The filing index links above go to sec.gov.